TGFB1 and cancer: These data support the concept that the upregulation of TGFβ signaling in late-stage CRC induces a tumor-friendly microenvironment by directly regulating innate and adaptive immune cells, as well as tumor resident cells such as cancer-associated fibroblasts (CAFs), as discussed in the following sections.